Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
1991.
Catatonia: a contemporary approach.
The Journal of Neuropsychiatry and Clinical Neurosciences,
Vol. 3,
Issue. 3,
p.
334.
Manschreck, Theo C.
1992.
Phenomenology, Language & Schizophrenia.
p.
258.
Barnes, Thomas R. E.
1992.
Clinical assessment of the extrapyramidal side effects of antipsychotic drugs.
Journal of Psychopharmacology,
Vol. 6,
Issue. 2,
p.
214.
Tamlyn, D.
McKenna, P. J.
Mortimer, A. M.
Lund, C. E.
Hammond, S.
and
Baddeley, A. D.
1992.
Memory impairment in schizophrenia: its extent, affiliations and neuropsychological character.
Psychological Medicine,
Vol. 22,
Issue. 1,
p.
101.
Sachdev, P.
1993.
Risk factors for tardive dystonia: a case‐control comparison with tardive dyskinesia.
Acta Psychiatrica Scandinavica,
Vol. 88,
Issue. 2,
p.
98.
Davis, Elizabeth J. B.
and
Borde, Milind
1993.
Wilson's Disease and Catatonia.
British Journal of Psychiatry,
Vol. 162,
Issue. 2,
p.
256.
Chen, E. Y. H.
Wilkins, A. J.
and
McKenna, P. J.
1994.
Semantic memory is both impaired and anomalous in schizophrenia.
Psychological Medicine,
Vol. 24,
Issue. 1,
p.
193.
Perera, K. M. H.
Ferraro, A.
and
Pinto, M. R. M.
1995.
Catatonia LSD Induced?.
Australian & New Zealand Journal of Psychiatry,
Vol. 29,
Issue. 2,
p.
324.
Chen, Eric Y.H
Shapleske, Jane
Luque, Rogelio
McKenna, Peter J
Hodges, John R
Calloway, S.Paul
Hymas, Nigel F.S
Dening, Tom R
and
Berrios, German E
1995.
The Cambridge Neurological Inventory: A clinical instrument for assessment of soft neurological signs in psychiatric patients.
Psychiatry Research,
Vol. 56,
Issue. 2,
p.
183.
Northoff, G.
Wenke, J.
Demisch, L.
Eckert, J.
Gille, B.
and
Pflug, B.
1995.
Catatonia: short-term response to lorazepam and dopaminergic metabolism.
Psychopharmacology,
Vol. 122,
Issue. 2,
p.
182.
Lynn, Sharon A
and
Plant, Rowena D
1995.
Dyskinesia in chronic schizophrenia: an examination of the psychiatric nurse's perspective and its implications for physiotherapy.
Clinical Rehabilitation,
Vol. 9,
Issue. 2,
p.
97.
Kitamura, Toshinori
Okazaki, Yuji
Fujinawa, Akira
Yoshino, Masahiro
and
Kasahara, Yomishi
1995.
Symptoms of Psychoses.
British Journal of Psychiatry,
Vol. 166,
Issue. 2,
p.
236.
Northoff, G.
Wenke, J.
Krill, W.
and
Pflug, B.
1995.
Ball experiments in 32 acute akinetic catatonic patients: Deficits of internal initiation and generation of movements.
Movement Disorders,
Vol. 10,
Issue. 5,
p.
589.
Haw, Camilla M.
Barnes, Thomas R. E.
Clark, Kate
Crichton, Paul
and
Kohen, Dora
1996.
Movement Disorder in Down's syndrome: A possible marker of the severity of mental handicap.
Movement Disorders,
Vol. 11,
Issue. 4,
p.
395.
CHEN, ERIC Y.H.
LAM, LINDA C.W.
CHEN, RONALD Y.L.
and
NGUYEN, DESMOND G.H.
1996.
Neurological Signs, Age, and Illness Duration in Schizophrenia.
The Journal of Nervous and Mental Disease,
Vol. 184,
Issue. 6,
p.
339.
Fink, Max
1996.
Neuroleptic malignant syndrome and catatonia: One entity or two?.
Biological Psychiatry,
Vol. 39,
Issue. 1,
p.
1.
Gaitonde, E. J.
Morris, A.
Sivagnanasundaram, S.
McKenna, P. J.
Hunt, D. M.
and
Mollon, J. D.
1996.
Assessment of association of D3 dopamine receptorMscI polymorphism with schizophrenia: Analysis of symptom ratings, family history, age at onset, and movement disorders.
American Journal of Medical Genetics,
Vol. 67,
Issue. 5,
p.
455.
Northoff, Georg
Demisch, Lothar
Wenke, Jens
and
Pflug, Burkhard
1996.
Plasma homovanillic acid concentrations in catatonia.
Biological Psychiatry,
Vol. 39,
Issue. 6,
p.
436.
Pfuhlmann, B.
and
Stöber, G.
1997.
The importance of a differentiated psychopathology of catatonia.
Acta Psychiatrica Scandinavica,
Vol. 95,
Issue. 4,
p.
357.
Northoff, G
Eckert, J
and
Fritze, J
1997.
Glutamatergic dysfunction in catatonia? Successful treatment of three acute akinetic catatonic patients with the NMDA antagonist amantadine..
Journal of Neurology, Neurosurgery & Psychiatry,
Vol. 62,
Issue. 4,
p.
404.
eLetters
No eLetters have been published for this article.